This inventor holds 1 USPTO granted patent. Top assignee: United States Surgical Corporation. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: The Innovative Contributions of Elliot A. Gruskin
Introduction
Elliot A. Gruskin is a notable inventor based in Killingworth, Connecticut. He has made significant contributions to the field of medical technology, particularly in the development of support materials for cell impregnation. His innovative work has the potential to enhance tissue engineering and regenerative medicine.
Latest Patents
Elliot A. Gruskin holds a patent for a support material for cell impregnation. This support material is fabricated from a semiabsorbable composite yarn, which consists of a nonabsorbable, elastic core yarn and an absorbable, relatively inelastic sheath yarn. The invention allows for the creation of prosthetic devices that can be impregnated with living cells. These materials can be cultured in vitro to increase the number of cells before being incorporated into the tissue structure of a host organism.
Career Highlights
Elliot A. Gruskin is associated with United States Surgical Corporation, where he has contributed to advancements in surgical technologies. His work focuses on improving the integration of living cells into prosthetic devices, which can lead to better outcomes in surgical procedures.
Collaborations
Throughout his career, Elliot has collaborated with notable professionals in the field, including Donald S. Kaplan and John J. Kennedy. These collaborations have fostered innovation and have contributed to the development of cutting-edge medical technologies.
Conclusion
Elliot A. Gruskin's contributions to the field of medical technology through his patent for support materials for cell impregnation highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the future of tissue engineering and regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
